🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma › Pennsylvania

Qorannoo klinikaalii Lymphoma Pennsylvania keessatti

Qorannoo 24 Lymphoma f Pennsylvania keessatti hirmaatuu jiru.

Magaalota Pennsylvania keessatti

Takkalaa qorannoo (Ingiliffa)

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

  • University of Pittsburgh Medical Center (UPMC), Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04234048

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Children's Hospital of Philadelphia, Philadelphia
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

  • University of Pennsylvania, Philadelphia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07015242

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07192471

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04094610

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

  • The Children's Hospital of Philadelphia (CHOP), Philadelphia
Namoota walitti qabaa jiraSadarkaa 1
24 Months – 18 Years · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06441331

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  • UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07221500

Collection of Tissue Samples for Cancer Research

  • University of Pittsburgh Medical Center, Pittsburgh
Namoota walitti qabaa jiraQorannoo ilaalaa
2 Months · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT00900198

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  • Research Site, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06137144

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Children's Hospital of Philadelphia, Philadelphia
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 21 Years · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT04870944

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

  • Research Site, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 18 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07509151

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  • Thomas Jefferson University, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06624085

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

  • Hospital of the University of Pennsylvania, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07082803

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Lehigh Valley Topper Cancer Center Institute, Allentown
  • Thomas Jefferson University, Philadelphia
  • West Penn Hospital, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT04104776

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Allegheny Health Network, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

  • Allegheny Health Network Cancer Institute, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

  • Children's Hospital of Philadelphia, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 0 hanga 29 · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT06934382

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • University of Pennsylvania, Abramson Cancer Center, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05131022

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

  • Dren Investigational Site 2, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Saint Christopher's Hospital for Children, Philadelphia
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • UPMC Hilman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT03328078

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

  • Geisinger Medical Center, Danville
  • Geisinger Cancer Center Dickson City, Dickson City
  • Community Medical Center, Scranton
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ama-2026 · NCT05006482

CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

  • University of Pennsylvania - Abramson Caner Center, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Sad-2025 · NCT06420089

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.